ValueAct Buys More Valeant Shares After Ackman Threw In The Towel

Hedge Fund ValueAct purchased three million more shares of Valeant Pharmaceuticals (NYSE: VRX) making them the second largest share holder after Bill Ackman announced his withdrawal from the company. GreedyPicks announced a long position this week as well on StockTwits (@GoodGreed) on the basis of negative sentiment and a .40 price to sales ratio. The stock rose over 4% after hours on the news.